Lv4
624 积分 2023-02-13 加入
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
6天前
已完结
The versatile interplay between steatotic liver disease and liver cancer
6天前
已完结
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
6天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
6天前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
6天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
6天前
已完结
Non-rigid Motion Correction for Ultrasound Localization Microscopy of the Liver in vivo
7天前
已完结
A researcher’s guide to preclinical mouse NASH models
8天前
已完结
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis
9天前
已完结
HIVEP1 aggravates NASH by reprogramming polyamine metabolism in T H 17 cells
9天前
已完结
皖公网安备34019202002308
